MONTVALE, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. announced today that it will report its third quarter financial results on Thursday, November 8, 2007, before the U.S. financial markets open. Management will provide a Company update and discuss the third quarter results during a conference call on Thursday, November 8, 2007, at 9:00 a.m. ET.
http://www.memorypharma.com
An audio replay of the conference call will be available from 11:00 a.m. ET on Thursday, November 8, 2007, until Thursday, November 15, 2007. To access the replay, please dial 888.286.8010 (U.S.) or 617.801.6888 (international) and enter pass code number 43832722. An audio replay of the conference call will also be available under the “Investors” section of the Company’s website during the same period.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer’s disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at http://www.memorypharma.com.
CONTACT: Jzaneen Lalani, General Counsel of Memory Pharmaceuticals Corp.,
+1-201-802-7249; or Laura Perry of Stern Investor Relations, Inc.,
+1-212-362-1200, for Memory Pharmaceuticals Corp.
Web site: http://www.memorypharma.com/
